Clinical Trial

Asprosin and Total Antioxidant/Oxidant Status in Diabetes and Periodontal Disease

Completed
View on ClinicalTrials.gov →
Summary
The goal of this observational study is to learn about how different periodontal health status affects the levels of asprosin (a hormone) and total oxidant/antioxidant status in the gingival crevicular fluid and blood serum of individuals with Type 2 diabetes. The main questions it aims to answer are: Do individuals with Type 2 diabetes and periodontal disease have different levels of asprosin and oxidative stress markers compared to diabetic individuals with healthy gingiva ? How do local changes in the gingiva relate to systemic (body-wide) biomarkers in diabetic patients? Participants with Type 2 diabetes will undergo a routine clinical periodontal examination to evaluate their gingival health. During their regular clinic visit, samples of fluid from around their gingiva (gingival crevicular fluid) and routine blood samples (serum) will be collected to measure and compare these biochemical markers
Trial Details
NCT Number NCT07691060
Lead Sponsor Saglik Bilimleri Universitesi
Conditions Periodontal Diseases, Gingival Diseases, Type 2 Diabetes
Enrollment 67 participants
Start Date 2025-07-01
Primary Completion 2025-12-17 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-08